2-(5-bromo-2-oxoindolin-3-ylidene)-N-(4-chlorophenyl)hydrazine carbothioamide | 482327-37-7

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 2-(5-bromo-2-oxoindolin-3-ylidene)-N-(4-chlorophenyl)hydrazine carbothioamide
• 英文别名: 1-[(5-bromo-2-oxoindol-3-yl)amino]-3-(4-chlorophenyl)thiourea
• CAS: 482327-37-7
• 化学式: C₁₅H₁₀BrClN₄OS
• 分子量: 409.694
• InChiKey: FAXJGKVYUUNPPC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.75
• 重原子数：
  23.0
• 可旋转键数：
  2.0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  65.52
• 氢给体数：
  3.0
• 氢受体数：
  3.0

反应信息

• 作为反应物：
  描述：

  2-(5-bromo-2-oxoindolin-3-ylidene)-N-(4-chlorophenyl)hydrazine carbothioamide 在 NaOH adsorbed on neutral alumina 作用下， 以 水 为溶剂， 生成
  参考文献：
  名称：

  AQUA MEDIATED ONE POT FACILE SYNTHESIS OF NOVEL THIOXO-1,2,4-TRIAZIN-5(2H)-ONE AND [1,2,4] TRIAZINO[5,6-A]INDOLE DERIVATIVES AND THEIR BIOLOGICAL ACTIVITIES

  摘要：

  Rapid and highly efficient one pot green chemical synthesis of substituted 6-(2-aminophenyl)-4-(4-substitutedphenyl)-3-thioxo-3,4-dihydro-1,2,4-triazin-5(2H)-one and 8-substituted-3,5-dihydro-2H-[1,2,4]triazino[5,6-b]indole is carried out in aqueous medium under microwave irradiation. Improved synthesis of potent bioactive Schiff and N-Mannich bases of hexahydro-1H-indole-2,3-dione is also reported. The title compounds are easily accessible by various approaches; even waste free approaches have been developed. The operational simplicity, environmentally benign conditions and high yield achieved in a very short reaction time are major benefits that meet the requirements of green production, including saving energy and high efficiency. The results obtained under microwaves are compared with that of conventional heating. Structural assignments are based on spectroscopic data. Compounds have also been screened for antibacterial and antifungal activities.

  DOI：

  10.4067/s0717-97072012000400004
• 作为产物：
  描述：

  4-溴苯胺 在 硫酸 、 溶剂黄146 、 sodium sulfate 作用下， 以 乙醇 为溶剂， 反应 4.0h， 生成 2-(5-bromo-2-oxoindolin-3-ylidene)-N-(4-chlorophenyl)hydrazine carbothioamide
  参考文献：
  名称：

  Synthesis and cytostatic evaluation of some 2-(5-substituted-2-oxoindolin-3-ylidene)-N-substituted hydrazine carbothioamide

  摘要：

  Various substituted 2-(5-substituted-2-oxoindolin-3-ylidene)-N-substituted hydrazine carbothioamide 4a-g and 2-(5-substituted-1-(4-substituted benzyl)-2-oxoindolin-3-ylidene)-N-substituted hydrazine carbothioamide 5a-k were synthesized. The compounds were evaluated for their cytostatic activity against human Molt4/C8 and CEM T-lymphocytes as well as murine L1210 leukemia cells. Several of these compounds were endowed with low micromolar 50%-inhibitory concentration (IC50) values, and some were virtually equally potent as melphalan. The most potent inhibitors against the murine leukemia cells were also most inhibitory against human T-lymphocyte tumor cells. 2-(5-fluoro-1-(4-fluorobenzyl)-2-oxoindolin-3-ylidene)-N-p-tolylhydrazine carbothioamide (5b) emerged as the most potent cytostatic compound among the tested compounds. The encouraging cytostatic data provide an adequate rationale for further modification of these molecular scaffolds.

  DOI：

  10.1007/s00044-010-9458-3

文献信息

• [EN] THIOSEMICARBAZONES WITH MDR1 - INVERSE ACTIVITY<br/>[FR] THIOSEMICARBAZONES À ACTIVITÉ ANTI-MDR1
  申请人：US HEALTH

  公开号：WO2012033601A1

  公开（公告）日：2012-03-15

  Disclosed herein are drug compounds that have MDR-inverse activity and thus are effective against multidrug-resistant cells. Exemplary compounds disclosed herein have the structure;Formula (I). Examples of the disclosed compounds have been found to have, inter alia, efficacy in directly treating multidrug resistant cells, rendering multidrug resistant cells susceptible to other chemotherapeutics and in some instances reversing multidrug resistance.

  本文披露了具有MDR逆转活性的药物化合物，因此对多药耐药细胞有效。本文披露的示例化合物具有下列结构；公式（I）。已发现披露的化合物的示例具有直接治疗多药耐药细胞的功效，使多药耐药细胞对其他化疗药物敏感，并在某些情况下逆转多药耐药。
• 取代吲哚酮-链接-取代-1,3-噻唑烷酮类衍生物及其制备方法和用途
  申请人：复旦大学

  公开号：CN114634505A

  公开（公告）日：2022-06-17

  本发明属于医药技术领域，具体为一种取代吲哚酮‑链接‑取代‑1,3‑噻唑烷酮类衍生物及其合成方法和用途。本发明采用计算机辅助药物设计技术，在深入分析PTP1B蛋白三维结构的基础上，选择具有良好生物活性的吲哚‑2‑酮和噻唑烷‑4‑酮片段作为结构母核，利用拼合原理，设计合成系列具有吲哚‑3‑取代的噻唑烷‑4‑酮基本骨架的PTP1B小分子抑制剂。目标化合物对PTP1B酶抑制活性测试结果表明：在浓度为5μg/mL下均显示出较好的PTP1B抑制活性，抑制率为50％以上；其半数抑制浓度(IC50值)介于4.00～12.60μM之间；最高抑制率达83.84％，IC50值为1.85μM。本发明为开发新型的PTP1B抑制剂提供理论依据和物质基础。
• 取代1H-吲哚-2-酮-链接-3,5-取代芳基-1,3-噻唑烷酮类衍生物
  申请人：复旦大学

  公开号：CN114634506A

  公开（公告）日：2022-06-17

  本发明属于医药技术领域，具体为一种取代1H‑吲哚‑2‑酮‑链接‑3,5‑取代芳基取代‑1,3‑噻唑烷酮类衍生物及其制备方法和应用，本发明采用计算机辅助药物设计技术，在分析PTP1B蛋白三维结构基础上，针对PTP1B的活性位点，选择具有广泛生物活性的1H‑吲哚‑2‑酮和噻唑烷‑4‑酮片段作为结构母核，利用拼合原理，设计并合成系列具有1H‑吲哚‑2‑酮‑链接‑3,5‑取代芳基‑1,3‑噻唑烷‑4‑酮基本骨架的PTP1B小分子抑制剂。对PTP1B酶抑制活性测试表明：化合物在浓度为5μg/mL下均显示出良好的PTP1B抑制活性，抑制率为50％以上；其IC50值在0.89～12.60μM之间。分子对接表明，目标化合物与酶的多个作用位点都有很好相互作用。本发明为开发新型的PTP1B抑制剂提供理论依据和物质基础。
• Karali; Gursoy, Il Farmaco, 1994, vol. 49, # 12, p. 819 - 822
  作者：Karali、Gursoy

  DOI：——

  日期：——
• Synthesis and Primary Cytotoxicity Evaluation of New 5-Bromo-3-substituted-hydrazono-1H-2-indolinones
  作者：Nilgün Karalı、Nalan Terzioğlu、Aysel Gürsoy

  DOI：10.1002/1521-4184(200211)335:8<374::aid-ardp374>3.0.co;2-k

  日期：2002.11

  In this study a new series of 5-bromo-3-[(3-subtituted-5-methyl-4-thiazolidinone-2-lidene)-hydrazono]-1H-2-indolinones (3a-i) and 5-bromo-3-[(2-thioxo-3-substituted-4,5-imidazolidinedione-1-yl)imino]-1H-2-indolinones (4a-f) was synthesized by the cyclization of 5-bromo-3-(N-substituted-thiosemicarbazono)-1 H-2-indolinones (2 a-i) with ethyl 2-bromopropionate in anhydrous ethanolic medium and oxalyl cloride in anhydrous diethyl ether, respectively Six compounds chosen as prototypes were evaluated in the 3-cell line, one dose in vitro primary cytotoxicity assay. Four of them were evaluated against the full panel of 60 human tumor cell lines at a minimum of five concentrations at 10-fold dilutions. Among the compounds tested, the 4-fluorophenylthiosemicarbazone derivative 2f showed the most favorable cytotoxicity This compound demonstrated the most marked effects on a breast cancer cell line (BT-549, log(10)GI(50) value -6.40), a non small cell lung cancer cell line (NCl-H23, log(10)GI(50) value -6.10), and an ovarian cancer cell line (IGROV1, log(10)GI(50) value -6.02).